Daily as of 3 Nov 16:00 ET
- Price
- above both $50.29 vs 50 $44.73 / 200 $42.90
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 5 Jun 2026 · projected 18 bars out
VCYT | VeracyteNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$50.29
+$1.29 (+2.63%)
Veracyte (VCYT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $50.01 vs 50 $42.77 / 200 $31.84
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 27 Jan 2025 · projected 28 bars out · tested 1 bar
4-hour as of 3 Nov 13:30 ET
- Price
- above both $50.68 vs 50 $46.26 / 200 $48.54
- Projection
- 🟨Golden cross estimated in 13 to 18 bars
- Test
- No active test
- Last cross
- 💀Death cross 31 Aug 2026 bar 1 · projected 27 bars out · tested 3 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 31 Aug 2026 | 💀Death | 4-hour | 27 bars out | 3 bar cross test |
| 5 Jun 2026 | 🟨Golden steep | daily | 18 bars out | Not tested |
| 21 May 2026 | 🟨Golden | 4-hour | 27 bars out | Not tested |
| 7 Apr 2026 | 💀Death steep | daily | 29 bars out | 2 bar cross test |
| 12 Feb 2026 | 💀Death | 4-hour | 26 bars out | Not tested |
About VCYT
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$54.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid